- Recent Funding
- Investors
- Optum Ventures
Optum Ventures portfolio
Optum Ventures has 5 portfolio companies on record at Recent Funding, with 1 investment in the last 12 months. It is a corporate venture investor based in Boston, US, founded in 2017. Its most recent investment on record is Bunkerhill Health's $55M Series B+ round in July 2026, alongside Y Combinator, Sequoia, Khosla Ventures and 1 other. By category, its portfolio leans toward Health and bio (5) and Consumer and social (3). It has co-invested with Y Combinator, Sequoia and Felicis, most often Y Combinator (2 rounds).
About Optum Ventures
Firm profile: Fundraising Fox Open Dataset v2026-09, CC BY 4.0. Track-record counts are theirs, not Recent Funding's.
What Optum Ventures invests in
- Health and bio · 5 · 100%
- Consumer and social · 3 · 60%
- HR and recruiting · 2 · 40%
- AI agents · 1 · 20%
- Data and analytics · 1 · 20%
Optum Ventures recent investments
| Company | Round | Date | Alongside |
|---|---|---|---|
| Series B+ · $55M | Y Combinator, Sequoia, Khosla Ventures (lead) +1 | ||
| Series A · $30M | Y Combinator, SV Angel, Sequoia (lead) +1 | ||
| Series B+ · $45M | Thrive Capital, Redpoint Ventures (lead), Founders Fund | ||
| Series B+ · $100M | Tiger Global Management (lead), Threshold Ventures, Redesign Health +2 |
How Optum Ventures invests
Share is of the 4 rounds on Recent Funding that name Optum Ventures. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.
Optum Ventures portfolio companies
BBunkerhill Health$55MSeries B+ · Jul 2026
GGarner Health$45MSeries B+ · Dec 2021
CCalibrate$100MSeries B+ · Aug 2021
CChamber Cardiobacker
RReemabacker
| Company | Round with Optum Ventures | Total raised | Latest raise |
|---|---|---|---|
AI agents |
Series B+ · $55M | $85M | Jul 16, 2026 Series B+ |
Health and bio |
Series B+ · $45M | $263M | May 28, 2026 Series B+ |
Health and bio |
Series B+ · $100M | $128M | Feb 3, 2024 Series B+ |
Health and bio |
backer | $8M | Feb 4, 2026 Series A |
Health and bio |
backer | $19M | Dec 2, 2025 Series B+ |
Most frequent co-investors
YY Combinator2 shared rounds · last Jul 16, 2026SSequoia2 shared rounds · last Jul 16, 2026
FFelicis2 shared rounds · last Jul 16, 2026
FFounders Fund2 shared rounds · last Dec 14, 2021
KKhosla Ventures1 shared round · last Jul 16, 2026
SSV Angel1 shared round · last Mar 1, 2023
TThrive Capital1 shared round · last Dec 14, 2021
RRedpoint Ventures1 shared round · last Dec 14, 2021
FForerunner Ventures1 shared round · last Aug 30, 2021
TTiger Global Management1 shared round · last Aug 30, 2021
TThreshold Ventures1 shared round · last Aug 30, 2021
RRedesign Health1 shared round · last Aug 30, 2021
Similar investors
AAngelini Ventures6 companies · 3 deals in 12 mo
MM Ventures4 companies
MMerck Global Health Innovation Fund4 companies
BBoehringer Ingelheim Venture Fund3 companies · 1 deal in 12 mo
CCVS Health Ventures3 companies · 1 deal in 12 mo
MMS&AD Ventures3 companies · 1 deal in 12 mo
Investors whose portfolios on Recent Funding center on the same category (Health and bio).
Portfolio companies are the companies on Recent Funding with a round that lists Optum Ventures, which is a subset of its real portfolio. API: /api/v1/investors/optum-ventures (get a free API key). More: the most active VC firms and new venture capital funds.
The week's top funded startups and market insights, in your inbox every Monday.
Unsubscribe anytime · privacy